InhibOx

CCDC logoOur latest announcement – that InhibOx and CCDC have formed a strategic partnership to create a powerful new computational drug discovery service capability – is another clear demonstration of how profoundly the world of pharma and biotech research is changing.

Drug discovery in the 21st century is undergoing the most dramatic change it has ever seen. Pharma companies are globalizing their R&D capabilities, seeking new collaboration partners and outsourcing activities from simple tasks to complete projects. And everyone in pharma, biotechs, CROs and academic research institutes is seeking new and better approaches to discovering new drug candidates. The federation of technologies of CCDC, InhibOx and Intelligensys, with a combined team of some of the world’s top scientists in computational drug discovery and development, is meeting that need head on – a full spectrum discovery and development service operation, set up for a world of outsourcing and collaboration.

An endothiapepsin structure with a docked inhibitor molecule shown in green

InhibOx is a pioneer in the development and application of new technologies to drive drug discovery. Our multidisciplinary research team has brought together breakthroughs in computational chemistry, cheminformatics, mathematics, cloud computing and software-as-a-service (SaaS) delivery methods to create DrugFinder: the next generation drug discovery platform.

DrugFinder delivers:

  • The industry’s most rigorous and powerful virtual screening service, built from the Scopius database of 65 million available and easily-synthesized compounds, stored with 3D models, multiple conformations and an array of calculated shape and electronic properties.

  • Lead identification capabilities that discover novel scaffolds from target- or ligand-based searches.

  • Powerful lead optimization approaches which efficiently refine the best candidate sets from which to build your libraries.

  • ADMET and formulation modelling brought through to early stage lead optimization - avoiding costly downstream failures.

  • Full service provision of samples to match the resulting hit sets, through our partner network.

InhibOx is built to address the new challenges in drug discovery in the new collaborative world.